Non-Hodgkin Lymphoma

1. Fanale MA, Younes A. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma. Drugs 67:333-50, 2007. 2.Mitrović Z, Aurer I, Radman I et al. FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell … ................
................